251 related articles for article (PubMed ID: 35760022)
21. β-Caryophyllene, a natural bicyclic sesquiterpene attenuates doxorubicin-induced chronic cardiotoxicity via activation of myocardial cannabinoid type-2 (CB
Meeran MFN; Al Taee H; Azimullah S; Tariq S; Adeghate E; Ojha S
Chem Biol Interact; 2019 May; 304():158-167. PubMed ID: 30836069
[TBL] [Abstract][Full Text] [Related]
22. (-)-Epigallocatechin-3-gallate alleviates doxorubicin-induced cardiotoxicity in sarcoma 180 tumor-bearing mice.
Yao YF; Liu X; Li WJ; Shi ZW; Yan YX; Wang LF; Chen M; Xie MY
Life Sci; 2017 Jul; 180():151-159. PubMed ID: 27956351
[TBL] [Abstract][Full Text] [Related]
23. Isoorientin attenuates doxorubicin-induced cardiac injury via the activation of MAPK, Akt, and Caspase-dependent signaling pathways.
Li S; Liu H; Lin Z; Li Z; Chen Y; Chen B; Huang L; Lin X; Yao H
Phytomedicine; 2022 Jul; 101():154105. PubMed ID: 35490492
[TBL] [Abstract][Full Text] [Related]
24. WGX50 mitigates doxorubicin-induced cardiotoxicity through inhibition of mitochondrial ROS and ferroptosis.
Tai P; Chen X; Jia G; Chen G; Gong L; Cheng Y; Li Z; Wang H; Chen A; Zhang G; Zhu Y; Xiao M; Wang Z; Liu Y; Shan D; He D; Li M; Zhan T; Khan A; Li X; Zeng X; Li C; Ouyang D; Ai K; Chen X; Liu D; Liu Z; Wei D; Cao K
J Transl Med; 2023 Nov; 21(1):823. PubMed ID: 37978379
[TBL] [Abstract][Full Text] [Related]
25. Meteorin-like protein attenuates doxorubicin-induced cardiotoxicity via activating cAMP/PKA/SIRT1 pathway.
Hu C; Zhang X; Song P; Yuan YP; Kong CY; Wu HM; Xu SC; Ma ZG; Tang QZ
Redox Biol; 2020 Oct; 37():101747. PubMed ID: 33045622
[TBL] [Abstract][Full Text] [Related]
26. Ethanol extracts of Rhaponticum uniflorum (L.) DC flowers attenuate doxorubicin-induced cardiotoxicity via alleviating apoptosis and regulating mitochondrial dynamics in H9c2 cells.
Hu B; Zhen D; Bai M; Xuan T; Wang Y; Liu M; Yu L; Bai D; Fu D; Wei C
J Ethnopharmacol; 2022 Apr; 288():114936. PubMed ID: 35007682
[TBL] [Abstract][Full Text] [Related]
27. AKR1B1 inhibition using NARI-29-an Epalrestat analogue-alleviates Doxorubicin-induced cardiotoxicity via modulating Calcium/CaMKII/MuRF-1 axis.
Syamprasad NP; Jain S; Rajdev B; Panda SR; Gangasani JK; Challa VS; Vaidya JR; Kundu GC; Naidu VGM
Chem Biol Interact; 2023 Aug; 381():110566. PubMed ID: 37257577
[TBL] [Abstract][Full Text] [Related]
28. Enhanced therapeutic efficacy of doxorubicin against multidrug-resistant breast cancer with reduced cardiotoxicity.
Zhang T; Li N; Wang R; Sun Y; He X; Lu X; Chu L; Sun K
Drug Deliv; 2023 Dec; 30(1):2189118. PubMed ID: 36919676
[TBL] [Abstract][Full Text] [Related]
29. Cardioprotective effect of crude polysaccharide fermented by Trametes Sanguinea Lyoyd on doxorubicin-induced myocardial injury mice.
Shen C; Yang B; Huang L; Chen Y; Zhao H; Zhu Z
BMC Pharmacol Toxicol; 2023 Jan; 24(1):1. PubMed ID: 36627724
[TBL] [Abstract][Full Text] [Related]
30. Palmatine attenuates the doxorubicin-induced inflammatory response, oxidative damage and cardiomyocyte apoptosis.
Cheng D; Liu P; Wang Z
Int Immunopharmacol; 2022 May; 106():108583. PubMed ID: 35151220
[TBL] [Abstract][Full Text] [Related]
31. Cardamonin protects against doxorubicin-induced cardiotoxicity in mice by restraining oxidative stress and inflammation associated with Nrf2 signaling.
Qi W; Boliang W; Xiaoxi T; Guoqiang F; Jianbo X; Gang W
Biomed Pharmacother; 2020 Feb; 122():109547. PubMed ID: 31918264
[TBL] [Abstract][Full Text] [Related]
32. Doxorubicin-loaded dextran-based nano-carriers for highly efficient inhibition of lymphoma cell growth and synchronous reduction of cardiac toxicity.
Fang Y; Wang H; Dou HJ; Fan X; Fei XC; Wang L; Cheng S; Janin A; Wang L; Zhao WL
Int J Nanomedicine; 2018; 13():5673-5683. PubMed ID: 30288040
[TBL] [Abstract][Full Text] [Related]
33. All-trans-retinoic acid ameliorates doxorubicin-induced cardiotoxicity: in vivo potential involvement of oxidative stress, inflammation, and apoptosis via caspase-3 and p53 down-expression.
Khafaga AF; El-Sayed YS
Naunyn Schmiedebergs Arch Pharmacol; 2018 Jan; 391(1):59-70. PubMed ID: 29085977
[TBL] [Abstract][Full Text] [Related]
34. Rosmarinic acid alleviates cardiomyocyte apoptosis via cardiac fibroblast in doxorubicin-induced cardiotoxicity.
Zhang X; Zhu JX; Ma ZG; Wu HM; Xu SC; Song P; Kong CY; Yuan YP; Deng W; Tang QZ
Int J Biol Sci; 2019; 15(3):556-567. PubMed ID: 30745842
[TBL] [Abstract][Full Text] [Related]
35. Emodin attenuates cardiomyocyte pyroptosis in doxorubicin-induced cardiotoxicity by directly binding to GSDMD.
Dai S; Chen Y; Fan X; Han J; Zhong L; Zhang Y; Liu Q; Lin J; Huang W; Su L; Huang Z; Ye B
Phytomedicine; 2023 Dec; 121():155105. PubMed ID: 37801893
[TBL] [Abstract][Full Text] [Related]
36. Aidi injection reduces doxorubicin-induced cardiotoxicity by inhibiting carbonyl reductase 1 expression.
Lu Y; Liu W; Lv T; Wang Y; Liu T; Chen Y; Jin Y; Huang J; Zheng L; Huang Y; He Y; Li Y
Pharm Biol; 2022 Dec; 60(1):1616-1624. PubMed ID: 35980105
[TBL] [Abstract][Full Text] [Related]
37. Angiotensin IV ameliorates doxorubicin-induced cardiotoxicity by increasing glutathione peroxidase 4 and alleviating ferroptosis.
Yang L; Guan J; Luo S; Yan J; Chen D; Zhang X; Zhong C; Yang P
Toxicol Appl Pharmacol; 2023 Nov; 479():116713. PubMed ID: 37838222
[TBL] [Abstract][Full Text] [Related]
38. Evaluation of the pharmacokinetics and cardiotoxicity of doxorubicin in rat receiving nilotinib.
Zhou ZY; Wan LL; Yang QJ; Han YL; Li Y; Yu Q; Guo C; Li X
Toxicol Appl Pharmacol; 2013 Oct; 272(1):238-44. PubMed ID: 23770382
[TBL] [Abstract][Full Text] [Related]
39. Algerian propolis: between protection of normal cells and potentialisation of the anticancer effects of doxorubicin against breast cancer cells via P-glycoprotein inhibition and cell cycle arrest in the S phase.
Rouibah H; Kebsa W; Lahouel M; Zihlif M; Ahram M; Aburmaileh B; Mansour Al Shhab MA; Al-Ameer HJ; Mustafa E
J Physiol Pharmacol; 2021 Apr; 72(2):. PubMed ID: 34374660
[TBL] [Abstract][Full Text] [Related]
40. Peficitinib ameliorates doxorubicin-induced cardiotoxicity by suppressing cellular senescence and enhances its antitumor activity.
Hua H; Zhao Q; Xia J; Dai QL; Bai SR; Wang XB; Zhou M
Int Immunopharmacol; 2023 Sep; 122():110630. PubMed ID: 37451017
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
